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ABSTRACT 
Inhibition of cytochrome P450 (P450) enzymes (CYP) has been shown to lower the 
metabolism of drugs that are P450 substrates and to consequently alter their pharmacokinetic 
profiles. Curcumin (CUR), piperine (PIP), and capsaicin (CAP) are spice components (SC) 
that inhibit the activities of a range of P450 enzymes, but the selection of which SC to be 
prioritized for further development as an adjuvant will depend on the ranking order of the 
inhibitory potential of the SCs on specific P450 isozymes. We used common human 
recombinant enzyme platforms to provide a comparative evaluation of the inhibitory 
activities of CUR, PIP, and CAP on the principal drug-metabolizing P450 enzymes. SC-
mediated inhibition of CYP3A4 was found to rank in the order of CAP (IC50 1.84 ± 0.71 
µM) ∼ PIP (2.12 ± 0.45 µM) > CUR (11.93 ± 3.49 µM), while CYP2C9 inhibition was in the 
order of CAP (11.95 ± 4.24 µM) ∼ CUR (14.58 ± 4.57 µM) > PIP (89.62 ± 9.17 µM). CAP 
and PIP were significantly more potent inhibitors of CYP1A2 (IC50 2.14 ± 0.22 µM and 
14.19 ± 4.15 µM, respectively) than CUR (IC50 > 100 µM), while all three SCs exhibited 
weak activity toward CYP2D6 (IC50 95.42 ± 12.09 µM for CUR, 99.99 ± 5.88 µM for CAP, 
and 110.40 ± 3.23 µM for PIP). Of the three SCs, CAP thus has the strongest potential for 
further development into an inhibitor of multiple CYPs for use in the clinic. Data from this 
study are also useful for managing potential drug–SC interactions.  
